AN GO GEN INC has a total of 20 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Canada, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are CEREGENE INC, MEDGENICS INC and UNIV NEBRASKA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 6 | |
#2 | Australia | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | United States | 2 | |
#6 | Brazil | 1 | |
#7 | Israel | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Enzymes | |
#4 | Peptides | |
#5 | Diagnosis and surgery | |
#6 | Syringes | |
#7 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Stewart Duncan J | 10 |
#2 | Stewart Duncan | 5 |
#3 | Karoubi Golnaz | 4 |
#4 | Courtman David | 4 |
#5 | Stewart Duncan John | 4 |
#6 | Langer Anatoly | 1 |
Publication | Filing date | Title |
---|---|---|
CA2450650A1 | Encapsulated cell therapy | |
CA2413269A1 | Injection system for gene delivery | |
AU2337801A | Angiopoietin analogs | |
CA2312142A1 | Injection system for gene delivery | |
EP1220679A1 | Cell-based gene therapy for the pulmonary system | |
CA2266805A1 | Cell-based gene therapy in the treatment of pulmonary disorders | |
US6004295A | Catheters | |
CA2227425A1 | Cell-based gene therapy |